Influenza A/B Inhibitor

Program Discovery Preclinical Phase 1 Phase 2 Phase 3
Influenza Influenza A/B Inhibitor
Discovery Phase in progress
Preclinical Phase not started
Phase 1 Phase not started
Phase 2 Phase not started
Phase 3 Phase not started

We are developing another class of influenza antivirals targeting influenza polymerase complex (PB1:PB2:PA) for the treatment of influenza A and B infections. We are currently improving antiviral potency and drug-like properties of the influenza A/B dual inhibitors.